Introduction
While hyperlipidemia is one of the important risk factors for atherosclerosis, hyperlipidemic animals generated by high-fat diet or genetic mutations have served for atherosclerosis study (1) . We recently established a line of Japanese wild mice with hyperlipidemia, i.e., spontaneously hyperlipidemic (SHL) mice (2) : Since these mice were derived from a KOR inbred strain (3) of Japanese wild mice Mus musculus molossinus, we termed these SHL mice KOR-Apoe"' in this paper. KOR-Apoesh' showed extremely high serum cholesterol levels and severe skin xanthoma but relatively mild aortic atherosclerosis ; they die before reaching one year of age. Molecular biological analyses revealed that apolipoprotein E (Apo E) is not expressed, and that the gene for Apo E (the Apoe gene) is grossly disrupted in these mice. et al. 
Results

Southern blot analysis
No apparent difference in restriction enzyme cleavage patterns of the Apoc1 and Apoc2 genes was found between KOR and KOR-Apoeshi (Figs. 1A, B) . In contrast, the pattern of the Apoe gene showed difference between the four lines of SHL mice and their parental strains of mice (Fig. 10) , indicating that the Apoeshl locus was introduced into congenic mice, and thus that the Apoe gene was disrupted in a manner identical to that in KORApoeshl.
Western blot analysis
Consistent with the result of Southern blot analysis, Western blot analysis revealed that ApoE protein was deficient in all four lines of SHL mice ( Fig. 2A ). Intriguingly apolipoprotein A-I (hereafter Apo A-I) was decreased in all four lines of SHL mice when compared with their parental strains (Fig. 2B ). In addition, it was found that the electromobility of Apo A-I in C57BL/6 and B6. KOR-Apoeshl was distinct from other strains of mice.
Lipoprotein profile
Lipoprotein profiles of the four lines of SHL mice were quite different from their parental strains (Fig. 3A) . However, no apparent distinction of the profile was observed among four lines of SHL (Fig. 3B) . Serum cholesterol level All four lines of SHL mice were hypercholesterolemic, but hypercholesterolemia was much more prominent in KOR-Apoeshl than in congenic SHL mice (Fig. 4) Xanthoma of skin Macroscopic observation of the skin revealed severe xanthoma in KOR-Apoeshl (Fig. 8) , while the xanthoma was moderate in B6.KOR-Apoeshl and hardly apparent in C.KOR-Apoesh' and C3.KOR-Apoeshl.
Discussion
A growing body of evidence indicates a clear relationship between hypercholesterolemia and atherosclerosis in humans (15) (16) (17) . However, similar levels of hyperlipidemia in different individuals do not necessarily result in similar levels of atherosclerosis in these individuals. This individuality is probably due to many factors including associated diseases (e.g. diabetes mellitus), life style, age and genetic background.
Since family histories often exist in persons with atherosclerosis, genetic backgrounds would certainly be a risk factor. We previously described the distinction in severity of atherosclerosis between two lines of Apo E deficient mice, i.e., original SHL mice (KOR-Apoeshl) and Apo E knockout mice, despite the fact that the Apoe gene was grossly disrupted in both of these mice (2) . To explain the distinction, we proposed two possibilities : mutation(s) of apolipoprotein genes (Apoc1 and/or Apoc2) adjacent to Apoe in KORApoeshi and different genetic backgrounds in KOR-Apoeshl and Apo E knockout mice. Our results presented here tend to negate the first possibility, since Southern blot analysis did not find any gross disruption of the Apocl and Apoc2 genes in KOR -Apoeshl. Although the result of Southern analysis using partial genes as a probe does not exclude the possibility of minute mutation of the Apocl and Apoc2 genes, it favors the second possibility of the involvement of genetic backgrounds, and alteration of genetic backgrounds by producing congenic mice did indeed alter the phenotypes caused by the Apoeshl allele. All four lines of SHL mice were hyperlipidemic, but the cholesterol levels of congenic SHL mice with genetic backgrounds of laboratory mice were much more moderate than those of KOR-Apoeshl and were comparable to those of Apo E knockout mice (2). The extremely high and exponentially decreasing initial segment of cholesterol level before weaning that was observed in KORApoeshl disappeared in congenic SHL mice. One might think that this unusual initial segment in KOR-Apoeshl might be caused by the high cholesterol level in the milk. However, this was not the case, since pups of KORApoeshl were nursed by heterozygous KOR-Apoeshl, which were normocholesteromic (2) . Similarly, xanthoma of the congenic mice was more severe in KOR-Apoeshl than in the congenic SHL mice. In contrast, atherosclerosis was milder in KOR-Apoeshl than in the congenic SHL mice. Strain differences of hyperlipidemia, xanthoma and atherosclerosis were also observed among the three lines of congenic SHL mice.
The "genetic backgrounds" determining phenotype distinctions among strains of SHL mice probably consist of polymorphism of various proteins related to atherogenesis and/or lipid metabolism.
Apo A is known to be highly polymorphic and is implicated in cardiovascular risk (18) . In Apo E knockout mice, over-expression of Apo A-I inhibits foam cell formation in atherosclerotic plaque (19) , increases HDL (20) and indeed corrects atherosclerosis (21). These previous findings led us to test the hypothesis that polymorphism of Apo A-I is involved in variation of atherosclerosis among SHL strains.
Indeed, the polymorphism was observed between B6.KOR-Apoeshl and other lines of SHL mice and also between B6 and other parental strains. This Apo A-I polymorphism may explain the most severe atherosclerosis in B6.KOR-Apoeshl, at least in part. However, it does not explain the variation among other strains of SHL mice, particularly the lightest atherosclerosis in the original SHL mice, i.e., KOR-Apoensjl suggesting the polymorphism of other proteins.
In the absence of Apo E, cholesterol is probably metabolized with the assistance of apolipoprotein B (Apo B), whose polymorphism at the gene level is found among inbred laboratory mice strains (22). Mouse liver, unlike the human liver, produces lipoproteins containing, an isoform of Apo B, i.e., Apo B48, which is translated with assistance of ApoB mRNA editing catalytic polypeptide-1 (APOBEC-1) (23). Apo E knockout mice have a distinct accumulation of Apo B48-containing lipoproteins, along with abnormally low levels of Apo B-containing lipoproteins (24, 25). It is conceivable that polymorphism of Apo B and APOBEC-1 are involved in the phenotype variation in the four lines of SHL mice. Polymorphism of lipoxygenase is another example that may account for phenotype distinctions in SHL strains. In Apo E knockout mice disruption of the 12/15-lipoxygenase gene has been shown to diminish atherosclerosis (26). We will continue to examine the polymorphism of these and other candidate proteins accountable for phenotype distinctions among SHL strains.
Another approach is the linkage analysis and positional cloning of genes responsible for phenotype distinctions. Such an approach has been successfully employed to localize atherosclerosis susceptibility genes using recombinant inbred mice between atherosclerosis-susceptible C57BL/6 mice and atherosclerosis-resistant C3H/He or BALB/c mice (27). Similar linkage studies have localized eight such genes (28). The present four lines of SHL mice should be useful for such studies, since they include strains derived from both wild mice and laboratory mice. The long evolutionary distance between Japanese wild mice and laboratory mice would be beneficial for this purpose.
For example, the incidence of microsatellite marker polymorphism is over 80% between Japanese wild mice and one strain of laboratory mice, while it is around 46% between two strains of laboratory mice (29). This is advantageous for linkage analyses by crossing wild mice and laboratory mice.
Since KOR-Apoeshl was extremely hypercholesterolemic, serum cholesterol level would be a factor in determining the everity of xanthoma.
However, since Four lines of SHL mice with different genetic backgrounds would also be useful in developing a customized method for improvement of hyperlipidemia using diet or drug intake and considering an individual's genetic backgrounds.
We are currently examining the effect of polyphenol and taurine feeding on cholesterol levels and atherosclerosis in these SHL mice.
Note : Four lines of SHL mice are available upon collaboration with YM and MT. 
